Delaware Ivy Systematic Em Mkts Eq I IPOIX Fund Analysis

| Medalist Rating as of | See Macquarie Investment Hub

Morningstar’s Analysis IPOIX

Will IPOIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

As new managers continue to settle in, a change at the top.

Senior Analyst Jack Shannon

Jack Shannon

Senior Analyst

Summary

Delaware Ivy Systematic Emerging Markets Equity’s quantitative approach has some appealing aspects, but the team’s active track record is short and a recent comanager change leaves this strategy in less experienced hands. For now, investors would benefit from a wait-and-see approach.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center